Dimensional Fund Advisors’s VolitionRx Ltd VNRX Stock Holding History

Dimensional Fund Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,119	Closed	-$67K	–	3531
2022 Q1	$67K	Hold	1,119	–	–	﹤0.01%	3434
2021 Q4	$70K	Hold	1,119	–	–	﹤0.01%	3463
2021 Q3	$69K	Sell	1,119 -214	-16%	-$13.6K	﹤0.01%	3455
2021 Q2	$88K	Buy	+1,333	New	+$90.2K	﹤0.01%	3416

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's VNRX Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of VolitionRx Ltd (VNRX) in Q2 2022, closing a stake of 1,119 shares — an estimated $67K sold.

Dimensional Fund Advisors first reported a position in VNRX in Q2 2021 and held it in 4 quarters. The position peaked at $88K in Q2 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q2 2022.

Dimensional Fund Advisors reported no remaining VolitionRx Ltd position as of Q2 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 1,119 VolitionRx Ltd shares in Q2 2022, an estimated $67K.
Dimensional Fund Advisors first reported a position in VolitionRx Ltd in Q2 2021 and held it in 4 quarters.
Dimensional Fund Advisors's VolitionRx Ltd position peaked at $88K in Q2 2021.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.